Von Willebrand Disease Sleep Mattress Canada

8 min read

Table of Contents

• Understanding Von Willebrand Disease
• Types of VWD and Their Impact on Sleep
• Bruising, Skin Sensitivity, and Mattress Pressure
• Menorrhagia-Related Fatigue and Sleep Quality
• Joint Bleeding in VWD and Nighttime Comfort
• Iron Deficiency Anaemia and Restless Legs
• The Science of Gentle Pressure Relief
• Mattress Features for Von Willebrand Disease
• Sleep Strategies for VWD Patients
• Women with VWD: Special Sleep Considerations
• Canadian VWD Support and Resources
• Why We Recommend the Restonic ComfortCare
• Frequently Asked Questions
• Sources

Understanding Von Willebrand Disease

Von Willebrand disease is a bleeding disorder caused by a deficiency or dysfunction of von Willebrand factor (VWF), a protein that plays two critical roles in the blood clotting process. First, VWF acts as a molecular bridge that helps platelets stick to damaged blood vessel walls at the site of an injury. Second, VWF carries and protects factor VIII, one of the essential clotting proteins, in the bloodstream. When VWF is deficient or dysfunctional, both platelet adhesion and factor VIII levels can be affected, leading to prolonged bleeding.

VWD is the most common inherited bleeding disorder worldwide, affecting an estimated 1 percent of the population. However, many people with mild forms of the disease are never diagnosed because their symptoms are attributed to other causes or are considered normal variation. In Canada, the diagnosed prevalence is lower than the estimated true prevalence, suggesting that thousands of Canadians may be living with undiagnosed VWD.

Unlike haemophilia, which predominantly affects males, VWD affects men and women equally. However, the impact on women tends to be more severe because of menstruation, pregnancy, and childbirth, all situations that involve bleeding and where the ability to form clots efficiently is essential. Women with VWD often experience heavy menstrual periods (menorrhagia) as their first and most prominent symptom, and this chronic blood loss has significant consequences for energy levels, iron status, and sleep quality.

The symptoms of VWD extend beyond the obvious bleeding concerns. Chronic blood loss leads to iron deficiency anaemia, which causes fatigue, weakness, cognitive difficulty, and restless legs syndrome. The bruising that many VWD patients experience can be both physically uncomfortable and psychologically distressing. Joint bleeding, while less common than in haemophilia, does occur in more severe forms of VWD and can cause chronic pain. All of these symptoms converge on sleep, making the bedroom environment and mattress selection important considerations for managing the overall impact of the disease.

Types of VWD and Their Impact on Sleep

VWD is classified into three main types, each with different characteristics that influence how the disease affects sleep and what type of mattress support is most appropriate.

Type 1 VWD is the most common form, accounting for approximately 70 to 80 percent of all VWD cases. It involves a partial quantitative deficiency of VWF, meaning the protein is structurally normal but present in reduced amounts. Type 1 is generally the mildest form, with symptoms that may include easy bruising, heavy menstrual periods, prolonged bleeding from cuts, and nosebleeds. From a sleep perspective, Type 1 VWD primarily affects sleep through bruising sensitivity, menorrhagia-related fatigue, and the iron deficiency that results from chronic blood loss. Most Type 1 patients do well with a standard medium-firmness mattress that provides good pressure distribution.

Type 2 VWD involves qualitative defects in the VWF protein. The protein is present but does not function properly. Type 2 is subdivided into 2A, 2B, 2M, and 2N, each with different molecular abnormalities. Patients with Type 2 VWD may experience more significant bleeding symptoms than Type 1, including occasional joint bleeding in some subtypes. Type 2B VWD can be associated with thrombocytopenia (low platelet count), which may increase bruising sensitivity. Patients with Type 2 VWD may need a mattress with more attention to pressure distribution and joint support, particularly if joint bleeding has occurred.

Type 3 VWD is the most severe form, involving a near-complete absence of VWF and severely reduced factor VIII levels. Type 3 is rare, affecting approximately 1 in 500,000 people. Patients with Type 3 VWD can experience spontaneous joint and muscle bleeding similar to severe haemophilia, making their mattress needs comparable to those of haemophilia patients. Joint protection, gentle pressure relief, and responsive support for easy position changes are all critical features for Type 3 patients.

Bruising, Skin Sensitivity, and Mattress Pressure

Easy and excessive bruising is often the most visible symptom of VWD and the one that most directly relates to mattress selection. Understanding the mechanics of bruising in VWD helps explain why pressure distribution is such a critical mattress feature for these patients.

Bruises form when small blood vessels (capillaries) beneath the skin are damaged by mechanical force. In a person with normal VWF function, the damage is quickly sealed by platelets adhering to the vessel wall and forming a platelet plug. In VWD, this initial platelet plug formation is impaired, allowing more blood to leak from the damaged vessel into surrounding tissue before clotting occurs. The result is a bruise that is larger, darker, and more painful than what a person with normal clotting function would experience from the same mechanical force.

The mechanical force that causes bruising during sleep comes from body weight pressing against the mattress surface. This force is not evenly distributed. It concentrates at bony prominences where the skeleton is closest to the skin surface: the shoulders, hips, elbows, knees, and ankles. These are the areas where VWD patients most commonly develop sleep-related bruises.

Pressure mapping technology, which measures the force per unit area between the body and the mattress surface, reveals significant differences between mattress types. A firm, flat mattress can create peak pressures exceeding 80 mmHg at the hip of a side sleeper. A well-designed hybrid mattress with comfort layering typically reduces these peaks to 25 to 35 mmHg. For VWD patients, this pressure reduction translates directly into less capillary damage and fewer bruises.

The duration of pressure also matters. Sustained pressure over many hours is more likely to cause capillary damage than brief pressure. Because we spend six to nine hours on a mattress each night, even moderate pressure that would not cause bruising during brief contact can become problematic over a full night of sleep. A mattress that facilitates easy position changes helps VWD patients naturally redistribute pressure throughout the night, reducing the cumulative mechanical stress on any single area.

Skin sensitivity in VWD goes beyond just bruising. Many patients report that their skin feels more tender or sensitive to touch in general, particularly at sites of recent or healing bruises. This heightened sensitivity means that mattress surface texture matters more than it would for the average sleeper. A mattress cover with a smooth, soft surface that does not create friction or irritation against sensitive skin is an important feature for VWD patients.

Mattress seams, quilting patterns, and surface details that create textural variation can become pressure points for sensitive skin. When testing mattresses, VWD patients should pay attention to how the surface feels against their skin, not just how the underlying support feels. Lying directly on the mattress surface (rather than on top of display bedding) for at least several minutes gives the most accurate impression of how the surface will feel during actual sleep.

Menorrhagia-Related Fatigue and Sleep Quality

For the estimated 50 percent of women with VWD who experience menorrhagia (heavy menstrual bleeding), the impact on sleep is substantial and occurs through multiple interconnected pathways. This section addresses these connections in detail because menorrhagia is one of the most common and most undertreated symptoms of VWD.

Menorrhagia in VWD is defined not just by the volume of blood loss but by its impact on daily functioning. Many women with VWD lose more than 80 millilitres of blood per menstrual cycle, compared to the average of 30 to 40 millilitres. Some lose considerably more. This chronic monthly blood loss depletes iron stores over time, leading to iron deficiency anaemia that causes persistent fatigue, weakness, and reduced exercise tolerance. The fatigue of iron deficiency is distinct from normal tiredness; it is a deep, pervasive exhaustion that does not resolve with rest and that worsens with each menstrual cycle if iron is not adequately replaced.

The direct nighttime effects of menorrhagia are significant sleep disruptors. Heavy menstrual flow at night creates practical concerns about leaking through protection and staining bedding. This worry alone can delay sleep onset, cause lighter, more vigilant sleep, and prompt frequent awakenings to check or change protection. The need to get up during the night to manage flow interrupts sleep cycles and prevents the sustained periods of deep sleep that are essential for physical restoration.

Menstrual cramping, which is often more severe in women with VWD due to the larger volume of blood and clots the uterus must expel, adds a pain component to the sleep disruption. Cramps typically intensify during the night when pain-modulating hormones decline and when the body's attention to pain signals increases in the absence of daytime distractions. A mattress that supports comfortable positioning for managing cramps, particularly side lying with the knees drawn up, can help reduce this pain-related sleep disruption.

The hormonal fluctuations associated with the menstrual cycle also affect sleep architecture independently of bleeding symptoms. Progesterone, which rises in the luteal phase (the two weeks before menstruation), has mild sedative properties and promotes sleep. When progesterone drops at the onset of menstruation, this sleep-promoting effect is lost. The combination of hormonal sleep disruption, bleeding management concerns, cramping pain, and chronic fatigue from anaemia creates a particularly challenging sleep environment during menstruation.

The emotional and psychological toll of living with menorrhagia should not be underestimated as a sleep factor. Many women with VWD describe feeling embarrassed, frustrated, or isolated by their heavy periods. Concerns about managing flow during social situations, at work, or during travel create chronic stress that activates the body's stress response system. Elevated cortisol and adrenaline from chronic stress are well-established barriers to healthy sleep, creating a state of physiological arousal that opposes the relaxation needed for sleep onset.

Joint Bleeding in VWD and Nighttime Comfort

While joint bleeding is less common in VWD than in haemophilia, it does occur, particularly in patients with Type 3 VWD and some patients with Type 2 VWD. Even patients with Type 1 VWD may occasionally experience joint bleeding after injury or during periods of particularly low VWF levels. Understanding how joint bleeding in VWD differs from haemophilia helps guide appropriate mattress selection.

In VWD, joint bleeds tend to be less frequent and often less severe than in haemophilia, but they can still cause significant pain and progressive joint damage over time. The knees and ankles are the most commonly affected joints, similar to haemophilia. However, because the overall bleeding tendency in most VWD patients is milder, the progression of arthropathy (chronic joint disease) tends to be slower and less severe than in haemophilia.

The mattress needs for VWD patients with joint involvement overlap significantly with those for haemophilia patients but with some important distinctions. Because the joint damage in VWD is often less advanced, many patients do not need the aggressive pressure relief that severe haemophilia arthropathy requires. A medium-firmness mattress with good general pressure distribution is usually sufficient, rather than the softer surfaces that some severe haemophilia patients need.

During an acute joint bleed, however, the mattress needs of a VWD patient are essentially identical to those of a haemophilia patient. The affected joint is swollen, hot, and exquisitely tender. Any concentrated pressure on the joint intensifies the pain. A mattress that provides responsive contouring around the affected joint, without creating pressure peaks, can significantly improve comfort during the 24 to 72 hours that a typical joint bleed takes to resolve with treatment.

Patients with VWD who have experienced joint bleeding should discuss their joint health with their treatment centre and request periodic joint assessments. Early identification of joint damage allows for proactive interventions, including mattress optimization, physiotherapy, and treatment adjustments, that can slow progression and maintain sleep comfort.

Iron Deficiency Anaemia and Restless Legs

Iron deficiency is one of the most significant but often underappreciated connections between VWD and sleep disturbance. The chronic blood loss that characterizes VWD, whether from menorrhagia, frequent nosebleeds, gastrointestinal bleeding, or easy bruising, depletes iron stores over time. When iron stores become low enough, iron deficiency anaemia develops, and with it comes a constellation of symptoms that profoundly affect sleep.

Restless legs syndrome (RLS) is the sleep-specific symptom most directly linked to iron deficiency. RLS involves uncomfortable sensations in the legs, typically described as crawling, tingling, pulling, or aching, accompanied by an overwhelming urge to move the legs. These sensations characteristically worsen during rest and in the evening, making bedtime a particularly difficult period. The relationship between iron and RLS is well established: iron is essential for the production of dopamine in the brain, and when brain iron availability drops, dopamine function is impaired, leading to the movement disorder that characterizes RLS.

For VWD patients, the relationship between iron status and RLS creates a treatment challenge. Iron supplementation can improve RLS symptoms, but it must be balanced against any concurrent treatments and the underlying bleeding tendency. Oral iron supplements are the first-line approach, though they can cause gastrointestinal side effects (constipation, nausea, stomach upset) that may create their own sleep disruption. Intravenous iron infusion is an alternative for patients who cannot tolerate or do not respond to oral iron. VWD patients should work with their haematologist to monitor iron levels and optimize replacement therapy.

Beyond RLS, iron deficiency anaemia causes generalized fatigue that creates the same paradoxical sleep problem seen in other chronic fatigue conditions: patients are exhausted but unable to achieve restful sleep. The body remains in a state of physiological compensation, with increased heart rate and respiratory effort to maintain oxygen delivery despite reduced haemoglobin. This compensatory state opposes the cardiovascular relaxation needed for sleep onset and deep sleep.

A mattress that accommodates both the movement needs of RLS and the fatigue-related comfort needs of anaemia provides practical help for these interconnected problems. Responsive coil-based mattresses allow the leg movements of RLS without the resistance that dense foam can create, while providing the even pressure distribution that helps fatigued bodies rest more comfortably.

The Science of Gentle Pressure Relief

Pressure relief is a term used frequently in mattress marketing, but understanding what it actually means in clinical terms is important for VWD patients who need to minimize mechanical stress on their bodies during sleep.

Pressure relief refers to a mattress's ability to distribute body weight over a large surface area, reducing the peak pressure at any single contact point. The physics are straightforward: pressure equals force divided by area. For a given body weight (force), increasing the area over which that weight is distributed reduces the pressure at each point. A mattress that conforms closely to the body's contours increases the contact area, spreading weight more evenly and reducing peak pressures.

For VWD patients, there are two specific thresholds to consider. The first is the capillary closing pressure, approximately 32 mmHg, above which blood flow through the smallest vessels in the skin and subcutaneous tissue can be impaired. Sustained pressures above this threshold can cause tissue ischaemia (reduced blood supply) and increase the risk of capillary damage that leads to bruising. The second threshold is the pain pressure threshold, which varies by individual and body location but is generally in the range of 40 to 60 mmHg for most people. For VWD patients with tender bruises or joint sensitivity, this threshold may be lower.

The ideal mattress for a VWD patient keeps peak pressures below the capillary closing pressure across all contact areas. This is a more demanding requirement than what most people need from a mattress, and it eliminates some mattress types that would work fine for someone without a bleeding disorder. Very firm mattresses, futon-style sleeping surfaces, and older innerspring mattresses with minimal comfort layering typically cannot meet this pressure standard.

The comfort layer composition significantly influences pressure distribution. High-resilience polyurethane foam provides a responsive feel that returns to its original shape quickly after pressure is removed. This responsiveness facilitates easy position changes without the slow deformation and recovery that characterizes memory foam. For VWD patients who need to move frequently to manage RLS or redistribute pressure, a responsive comfort layer is generally preferable.

The thickness of the comfort layer also matters. A comfort layer that is too thin (less than 3 centimetres) may not provide enough cushioning to adequately reduce pressure peaks, particularly for side sleepers whose shoulders and hips concentrate significant weight on relatively small contact areas. A comfort layer of 5 to 8 centimetres generally provides adequate cushioning for VWD patients without creating the deep sinking that makes position changes difficult.

Mattress Features for Von Willebrand Disease

Building on the pressure relief principles discussed above, here are the specific mattress features that VWD patients should prioritize when shopping for a new mattress.

Individually wrapped coils: This remains the top recommendation for VWD patients, just as it is for haemophilia patients. Individually wrapped coils respond to body contours point by point, creating a pressure profile that adapts to your specific body shape and sleeping position. Higher coil counts provide more precise contouring. The Restonic ComfortCare Queen with 1,222 coils exemplifies this feature.

Smooth, soft cover fabric: The mattress cover is the surface that contacts your skin (through sheets), and its texture influences both comfort and bruising risk. Look for tightly woven cotton, bamboo-derived rayon, or other smooth, natural-fibre fabrics. Avoid mattress covers with heavy quilting patterns, raised seams, or rough synthetic textures that could create friction against sensitive skin.

Breathable construction: Temperature regulation is important for VWD patients for several reasons. Hot sleeping can increase inflammation at bruise sites, worsen restless legs symptoms, and interfere with the temperature drop that the body needs for sleep onset. A mattress with an open coil support system allows air to circulate beneath the comfort layers, dissipating heat more effectively than a solid foam base. Comfort layers with ventilation channels or open-cell foam structures further enhance breathability.

Moderate firmness: A firmness level of approximately 5 out of 10 (medium) is the optimal starting point for most VWD patients. This provides enough cushioning to distribute pressure below the capillary closing threshold at major contact points while maintaining enough support to keep the spine aligned. Individual adjustments may be needed based on body weight, sleep position, and specific symptom patterns.

Good motion transfer isolation: VWD patients who share a bed benefit from mattresses that minimize motion transfer. When a sleeping partner moves, rolls over, or gets in and out of bed, the vibrations transmitted through the mattress can cause awakenings that fragment sleep. Individually wrapped coils provide better motion isolation than interconnected coil systems, and comfort layers act as additional vibration dampeners.

Durable edge support: Strong edge support is particularly valuable for VWD patients who experience dizziness from anaemia. Sitting on the edge of the bed before standing helps prevent orthostatic hypotension (a drop in blood pressure upon standing) that can cause lightheadedness or fainting. A mattress with reinforced edges provides a stable seating surface for this transition.

Sleep Strategies for VWD Patients

The right mattress provides the foundation for better sleep, but comprehensive sleep improvement requires additional strategies tailored to the specific challenges of living with VWD.

Iron status management: Work with your healthcare provider to maintain adequate iron stores. Ferritin levels below 30 to 50 micrograms per litre are associated with increased RLS risk and reduced sleep quality. Regular monitoring and appropriate supplementation can prevent the iron depletion that drives some of the most disruptive sleep symptoms of VWD. Take iron supplements with vitamin C to enhance absorption, and avoid taking them with calcium, tea, or coffee, which inhibit iron uptake.

Menstrual cycle sleep planning: For women with VWD who experience menorrhagia, proactive sleep planning around the menstrual cycle can help mitigate the worst sleep disruption. In the days leading up to and during heavy flow, prepare the sleep environment for comfort: waterproof mattress protectors reduce the stress of potential leaking, extra absorbent protection provides longer overnight coverage, and pain management timed to bedtime can prevent cramping from disrupting sleep. Consider discussing with your haematologist whether prophylactic treatment before expected heavy periods is appropriate.

Consistent sleep schedule: Maintaining regular bed and wake times helps compensate for the sleep fragmentation that VWD symptoms can cause. Even when sleep is disrupted during the night, a consistent schedule helps maintain circadian rhythm alignment, which supports the body's overall sleep regulation. Try to keep your schedule within a 30-minute window, even on weekends.

Bedroom temperature: Keep the bedroom at 18 to 20 degrees Celsius for optimal sleep. VWD patients with iron deficiency anaemia may feel cold more easily due to reduced oxygen delivery to peripheral tissues. Adjust the temperature upward by a degree or two if needed, and use breathable natural-fibre bedding that allows easy layering.

Stress management: Living with a chronic bleeding disorder creates ongoing stress that can become a significant barrier to sleep. Cognitive behavioural strategies, mindfulness practices, and professional support can all help manage the anxiety and worry that often intensify at bedtime. Consider speaking with a psychologist or counsellor who has experience with chronic health conditions if sleep-related anxiety is a significant problem.

Physical activity: Regular moderate exercise improves sleep quality, helps manage iron metabolism, and supports joint health. For VWD patients, activities like swimming, cycling, walking, and yoga are generally well tolerated and low risk for bleeding. Avoid exercising within two to three hours of bedtime, as the arousal effect of exercise can delay sleep onset.

Women with VWD: Special Sleep Considerations

Because VWD affects women and men equally but has additional impact on women through menstruation, pregnancy, and menopause, this section addresses the specific sleep considerations that women with VWD face at different life stages.

Adolescence: Young women who have recently begun menstruating may not yet know they have VWD. Heavy periods that cause missed school days, require changing protection hourly, or cause iron deficiency are red flags that warrant investigation. Adolescent girls with heavy periods often develop significant sleep disruption during menstruation, including anxiety about nighttime leaking that can cause lasting negative associations with sleep. Early diagnosis and treatment of VWD can prevent the accumulation of iron deficiency and the establishment of anxiety-driven insomnia patterns.

Reproductive years: Women with VWD in their reproductive years face the dual challenge of managing menorrhagia and, potentially, pregnancy. During pregnancy, VWF levels typically increase (sometimes to normal ranges), which may temporarily improve bleeding symptoms and associated sleep disruption. However, the postpartum period brings a rapid decline in VWF levels, increasing the risk of postpartum haemorrhage and a return of bleeding symptoms at a time when sleep is already severely disrupted by newborn care. Planning for postpartum sleep, including a mattress that provides maximum comfort to facilitate faster sleep onset during limited sleep windows, is particularly important.

Perimenopause and menopause: The perimenopausal transition often brings irregular and sometimes heavier menstrual bleeding that can worsen VWD symptoms. Hot flushes, night sweats, and mood changes add additional layers of sleep disruption. A mattress with excellent breathability and temperature regulation becomes especially important during this period. After menopause, when menstruation ceases, many women with VWD experience improvement in their overall bleeding burden and iron status, which can lead to better sleep quality. However, menopausal bone density loss combined with any VWD-related osteopenia requires ongoing attention to mattress support.

Hormonal treatment considerations: Some women with VWD use hormonal treatments (oral contraceptives, hormonal IUDs, or tranexamic acid) to manage menorrhagia. These treatments can have their own effects on sleep. Hormonal contraceptives may cause mood changes that affect sleep. Tranexamic acid is generally well tolerated but can cause gastrointestinal upset in some women. Desmopressin (DDAVP), used to boost VWF levels, can cause fluid retention and headaches that may disrupt sleep. Understanding these treatment-sleep interactions helps women make informed decisions with their healthcare providers.

Canadian VWD Support and Resources

Canada provides several resources for VWD patients, and connecting with these resources can indirectly improve sleep by reducing the stress and uncertainty that come with managing a chronic bleeding disorder.

The Canadian Hemophilia Society (CHS) serves patients with all inherited bleeding disorders, including VWD. Their website provides educational materials, connects patients with local chapters, and advocates for improved care and coverage across Canadian provinces. Local chapter events provide opportunities to meet other VWD patients who can share practical tips for managing daily challenges, including sleep.

Bleeding disorder treatment centres across Canada provide multidisciplinary care that addresses the full spectrum of VWD complications. In Ontario, centres in Hamilton, Toronto, Ottawa, and London provide comprehensive care including haematology, gynaecology (for menorrhagia management), physiotherapy (for joint issues), and social work (for emotional and practical support). Patients should not hesitate to raise sleep concerns with their treatment centre team, as sleep quality significantly affects overall health and quality of life.

The Network of Rare Blood Disorder Organizations (NRBDO) is a coalition of patient groups that advocates for improved access to treatment and support services for Canadians with rare blood disorders. Their advocacy efforts have contributed to improved provincial coverage for bleeding disorder treatments, which indirectly supports sleep quality by ensuring patients can access the therapies that manage their symptoms.

Why We Recommend the Restonic ComfortCare

At Mattress Miracle, we recommend the Restonic ComfortCare line for VWD patients because its design directly addresses the pressure relief, responsiveness, and breathability needs discussed throughout this guide.

The Queen-size Restonic ComfortCare with 1,222 individually wrapped coils provides the precise contouring that VWD patients need to keep peak pressures below the capillary closing threshold. Each coil responds independently to the body weight placed on it, creating a pressure profile that adapts to your specific body shape and sleeping position. For side sleepers, the coils under the shoulder compress more than those under the waist, allowing the shoulder to sink in without creating excessive pressure while maintaining spinal alignment.

The responsive comfort layers of the Restonic ComfortCare allow easy position changes without the resistance that dense memory foam can create. For VWD patients with restless legs from iron deficiency, this responsiveness means that leg movements encounter minimal resistance, reducing the effort and awakening potential of each movement. For patients who need to change positions frequently to redistribute pressure, the mattress facilitates rather than resists these transitions.

The open coil support system promotes airflow beneath the comfort layers, helping to maintain a neutral sleeping temperature. This breathability benefits VWD patients dealing with perimenopausal hot flushes, anaemia-related temperature sensitivity, or medication side effects that affect thermoregulation.

Shop: Explore The Full Mattress Range